The Niche

Stem cell trials for the heart, getting bigger

The FDA has given the go-ahead for a medium-scale trial to test bone-marrow cells to treat heart disease. Previously, the company had tested using patients’ own cells for heart therapy, but this time they hope to use cells derived from other patients. An April release from the company describes another, smaller trial using non-self or allogeneic cells. The just-announced trial will include study 15 control patients plus 45 patients who will receive different doses of cells, and patients’ outcomes will be followed for a year. If done correctly, such a design could answer important, growing questions in the use of these mesenchymal cells for heart disease. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE